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Tsung-Lin Cheng1,2,6, Yu-Ting Wu1,6, Chao-Han Lai2, Yuan-Chung Kao1,2, Cheng-Hsiang Kuo1,2,
Shu-Lin Liu1, Yun-Yan Hsu1, Po-Ku Chen1, Chia-Fong Cho1, Kuan-Chieh Wang1, Wei-Ling Lin1,
Bi-Ing Chang2, Chun-Ming Chen3, Hartmut Weiler4, Guey-Yueh Shi1,2 and Hua-Lin Wu1,2,5
The membrane glycoprotein thrombomodulin (TM) has been implicated in keratinocyte differentiation and
wound healing, but its specific function remains undetermined. The epidermis-specific TM knockout mice were
generated to investigate the function of TM in these biological processes. Primary cultured keratinocytes
obtained from TMlox/lox; K5-Cremice, in which TM expression was abrogated, underwent abnormal differentiation
in response to calcium induction. Poor epidermal differentiation, as evidenced by downregulation of the terminal
differentiation markers loricrin and filaggrin, was observed in TMlox/lox; K5-Cre mice. Silencing TM expression in
human epithelial cells impaired calcium-induced extracellular signal–regulated kinase pathway activation and
subsequent keratinocyte differentiation. Compared with wild-type mice, the cell spreading area and wound
closure rate were lower in keratinocytes from TMlox/lox; K5-Cre mice. In addition, the lower density of
neovascularization and smaller area of hyperproliferative epithelium contributed to slower wound healing in
TMlox/lox; K5-Cre mice than in wild-type mice. Local administration of recombinant TM (rTM) accelerated healing
rates in the TM-null skin. These data suggest that TM has a critical role in skin differentiation and wound healing.
Furthermore, rTM may hold therapeutic potential for the treatment of nonhealing chronic wounds.
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INTRODUCTION
Cutaneous wound healing is a highly integrated physiological
process that involves several overlapping biochemical and skin
cell interactions (Werner et al., 2007). This process involves the
coordination of interactions among several distinct cell types,
including keratinocytes, fibroblasts, endothelial cells, and inflam-
matory cells that emerge in wounds. Cytokines and growth
factors originating from these cells, such as IL-1, transforming
growth factor-b, and a variety of other growth factors (Singer and
Clark, 1999) participate in the cellular interactions and have
essential roles in coordinating the progress of wound healing
through the regulation of cellular proliferation, migration, and
differentiation. Similar to these secreted mediators, soluble
thrombomodulin (sTM) may have a role in cutaneous wound
healing through the regulation of cell migration and proliferation
(Cheng et al., 2011). However, the physiological significance of
membrane-bound TM remains to be explored.
TM, a well-characterized cell surface anticoagulant glyco-
protein, is expressed in endothelial cells, epidermal keratino-
cytes, and some other types of cells (Raife et al., 1994; Esmon,
1995). TM contains five functional domains: an NH2-terminal
lectin-like region (TM domain 1 (TMD1)), an EGF-like domain
(TM domain 2 (TMD2)) consisting of six EGF-like repeats, an
O-glycosylation site–rich domain (TM domain 3 (TMD3)), a
transmembrane domain (TM domain 4 (TMD4)), and a
cytoplasmic tail (TM domain 5 (TMD5)), all of which exert
various biological functions. In blood vessels, TM inhibits the
procoagulant activity of thrombin by increasing the thrombin-
dependent activation of anticoagulant protein C (Esmon and
Owen, 1981). Deletion of TM lectin-like domain (TMD1)
impairs the endocytic route of cells and anti-inflammatory
properties in transgenic mice (Conway et al., 1997, 2002). The
last three EGF-like structures of TMD2 are required for protein
C-activating cofactor activity and also anticoagulant activity
(Zushi et al., 1989). During the early phase of cutaneous
wound healing, TM expression has been highly augmented in
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the hyperproliferative epithelium (HE) in humans and mice
(Peterson et al., 1999), yet its function remains controversial.
Keratinocyte-specific overexpression of human TM using the
keratin 14 promoter did not have a significant impact on the
squamous differentiation or re-epithelialization of cutaneous
wounds but modulated collagen reconstitution of the wound
matrix (Raife et al., 1998). On the other hand, no significant
differences in the rate or extent of re-epithelialization during
cutaneous wound healing were observed in various TM-
deficient mice such as heterozygous TM-deficient (TMþ / ),
compound heterozygous (TMpro/ ), and TM / chimeric
mice (Peterson et al., 1999). The ectodomain of TM protein,
which includes the EGF-like domain (TMD2), has mitogenic
activity toward fibroblasts and also promotes angiogenesis
(Hamada et al., 1995; Shi et al., 2005). Our recent study
suggested that TM ectodomains are shed by a rhomboid
intramembrane serine protease, rhomboid-like-2 (RHBDL2),
during the early phase of wound healing, and the TM
ectodomain appears to be an autocrine/paracrine factor
in wound healing (Cheng et al., 2011). Because 3,4-
dichloroisocoumarin, a rhomboid intramembrane serine
protease inhibitor, suppresses TM ectodomain shedding and
wound healing, sTM released by RHBDL2 is considered
essential for proper wound healing. Nevertheless, a definite
role for sTM during the wound healing process is difficult to
establish because of the possible nonspecific inhibitory effects
of 3,4-dichloroisocoumarin in this process. In addition, the
function of the membrane-bound TM in the neoepidermis has
rarely been investigated in previous studies.
To avoid embryonic lethality that occurs following TM
knockout, and to specifically explore the functions of epithe-
lial TM in cell differentiation and the wound healing process,
skin-specific TM-null mice with conditional disruption of TM
were generated using the Cre-loxP recombination technology.
These tissue-specific TM-deleted mice were used to reappraise
the role of TM and its contribution to cutaneous wound
healing. We bred these TMlox/lox mice with keratin 5-Cre
recombinase (K5-Cre) transgenic mice (Isermann et al., 2001;
Liang et al., 2009), instead of using a cell model, to produce
TMlox/lox; K5-Cre mice. This study may help clarify the role of
epithelial TM, especially the membrane-bound form, on
differentiation and wound healing.
RESULTS
Abrogation of TM expression causes abnormal differentiation of
mouse keratinocytes
To verify the successful generation of skin-specific TM knock-
out mice, TM expression was analyzed in the epidermis of
TMlox/lox; K5-Cre mice. The results of reverse transcriptase–
PCR and western blotting confirmed that Cre-mediated
recombination abolishes TM expression at the mRNA and
protein levels in the epidermis (Figure 1a and b). It has
been shown that calcium induces TM expression in the
primary cultured keratinocytes harvested from the mouse
tail skin (Caldelari et al., 2000). In our study, incubation of
keratinocytes from TMlox/lox mice with 1.2 mM calcium
induced strong TM expression, whereas those from TMlox/lox;
K5-Cre mice did not express TM under similar conditions.
In addition, the adhesion molecule E-cadherin localized to the
cell junctions of keratinocytes from TMlox/lox mice, but not
to those from TMlox/lox; K5-Cre mice (Figure 1c). Moreover,
calcium could not trigger the upregulation of epidermal
differentiation markers on primary cultured keratinocytes from
TMlox/lox; K5-Cre mice (Figure 1d).
Hematoxylin and eosin staining of tissue sections obtained
from mouse tails of TMlox/lox and TMlox/lox; K5-Cre mice skin
showed significant differences (Figure 2a and b). The epider-
mal keratinocytes of TMlox/lox; K5-Cre mice showed few flat
nuclei, which are characteristic of terminal differentiation
(Figure 2c and d). TM expression was undetectable in the
TMlox/lox; K5-Cre mice compared with TMlox/lox mice
(Figure 2e and f). The expression of markers of terminal
differentiation in keratinocytes, namely, loricrin and filaggrin,
was downregulated in TM-null skin (Figure 2g–j). Taken
together, these results suggested that TM has a role in
keratinocyte differentiation and cell–cell adhesion.
TM silencing impairs calcium-induced extracellular
signal–regulated kinase (ERK) phosphorylation and
keratinocyte differentiation
In this study, stable TM knockdown HaCaT cells (Figure 3a)
were used to investigate the role of TM in calcium-triggered
differentiation and the underlying molecular mechanism.
Consistent with previous studies showing that calcium induces
keratinocyte differentiation through the activation of Ras-
independent Raf/MEK/ERK signaling (Schmidt et al., 2000),
calcium treatment caused ERK phosphorylation in parental
HaCaT and vector-transfected cells. In TM-silenced TM short
hairpin RNA cells, however, calcium treatment failed to
induce ERK phosphorylation at 30 minutes or upregulation of
loricrin at 24 hours (Figure 3b and c). These results suggested
that TM expression in keratinocytes has a critical role in
calcium-induced keratinocyte differentiation and which may
through the ERK pathway.
TM knockout keratinocytes exhibit decreased spreading and
slow migration ability
Spreading on a flat surface is one of the important character-
istics of epithelial cell differentiation (Micallef et al., 2009). To
further investigate the role of TM in cell differentiation,
primary keratinocytes from transgenic mice were cultured in
high calcium medium (1.2 mM) for 24 hours under a low cell
density condition. The spreading area of each cell wasB75%
smaller in primary keratinocytes derived from TMlox/lox; K5-
Cre mice than in those from their TMlox/lox littermates
(Figure 4a and b). Our previous studies demonstrated that
TM functions as a cell adhesion molecule and is an ezrin-
interacting protein that promotes collective cell migration.
Here, a wound healing assay with primary cultured keratino-
cytes was performed to assess cell migration ability. The
results showed a slower healing response in cells from
TMlox/lox; K5-Cre mice than in those from TMlox/lox
(Figure 4c), with a recovery rate of approximately one-sixth
of that observed in the TMlox/lox mice (Figure 4d). Taken
together, these data suggested that membrane-bound TM in
keratinocytes contributes to cell differentiation and migration.
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Knockout of TM in the epidermis delays wound recovery in vivo
The expression of TM is highly enhanced in the HE during the
early phases of cutaneous wound healing in humans and mice
(Peterson et al., 1999). The in vivo effects of TM expression in
keratinocytes were examined using a wound healing model in
mice, in which a full-thickness transdermal incision was made
along the dorsal spine and the rate of wound closure was
measured. Wound closure was significantly delayed in TM
knockout mice compared with their TMlox/lox littermates
(Figure 5a and b). In addition, intense neovascularization
was observed near the incision site in TMlox/lox mice 6 days
after injury, whereas the wound region of TMlox/lox; K5-Cre
mice showed significantly less neovascularization (Figure 5c).
The number of branching points in dermal blood vessels at the
incision was analyzed using a dissecting microscope, which
showed a 50% reduction of branching points in TMlox/lox; K5-
Cre mice compared with that in TMlox/lox mice (Figure 5d).
Histological sections of the wound area obtained 3 and 5 days
after injury were examined. On day 5, the area of HE was
B50% smaller in TMlox/lox; K5-Cre mice than in TMlox/lox mice
(Figure 5e and f). These results suggested that TM may be
involved in several processes associated with the formation of
HE and cutaneous wound healing, such as neovascularization
and epithelial proliferation.
Recombinant TM accelerates cutaneous wound healing in
TMlox/lox; K5-Cre mice
Our previous study indicated that sTM released by serine
protease RHBDL2 is one of the key molecules involved in
cutaneous wound healing. An analysis of tissue extracts and
the skin culture medium 5 days after the incision showed
lower levels of TM in the tissue extract and less sTM released
from the skin samples of TMlox/lox; K5-Cre mice than from
those of TMlox/lox mice (Figure 6a), suggesting that reduced
sTM might contribute to delayed wound healing in the TM-
null epidermis. Therefore, we tested whether TM supplemen-
tation might accelerate wound healing in TMlox/lox; K5-Cre
mice. Local intradermal injection of human recombinant TM
containing all the ectodomains of TM (rTMD123) significantly
improved the rate of wound healing (Figure 6b). The western
blot analysis showed the existence of injected human
rTMD123 for at least 48 hours after the last injection
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Figure 1. Tissue-specific recombination in TMlox/lox; K5-Cre mice. Tissue-specific deletion of thrombomodulin (TM) was detected at skin epidermis from adult
mouse by (a) reverse transcriptase–PCR (RT–PCR) and (b) western blot analysis. (c) Immunofluorescence staining of TM and E-cadherin in primary cultured
keratinocytes (passages 3–5) from adult TMlox/lox; K5-Cre mice and TMlox/lox mice after culture in 1.2 mM calcium medium for 96 hours. Arrows indicate the local
expression of E-cadherin at cell–cell contacts. Bar¼ 100mm. (d) Detection of calcium-induced differentiation markers in cultured keratinocytes by western blotting.
K5-Cre, keratin 5-Cre recombinase.
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(Figure 6c). Furthermore, administration of mouse rTMD23,
an angiogenic factor (Shi et al., 2005), caused a similar
enhancement of cutaneous wound healing as rTMD123 in
TMlox/lox; K5-Cre mice (Figure 6d and e).
DISCUSSION
Skin injury promotes TM expression in the neoepidermis
(Peterson et al., 1999), suggesting that TM has a role in
wound healing and epidermis development. To unveil the
functions of epithelial TM, several heterozygous transgenic
mice and keratinocyte-specific TM overexpression mice have
been generated because TM knockout in mice results in
lethality (Healy et al., 1995; Raife et al., 1998; Peterson
et al., 1999). In our previous work, skin injury induced the
expression of rhomboid serine protease RHBDL2, which
caused the release of sTM, a possible intrinsic factor
promoting wound healing (Cheng et al., 2011). In this study,
keratinocyte-specific TM knockout mice that did not show
physiological differences from control mice were generated to
further examine the role of TM in the wound healing process.
The Cre-loxP strategy resulted in a significant abolishment of
TM expression detected by reverse transcriptase–PCR and
western blotting in transgenic keratinocytes, and TM expres-
sion in these keratinocytes was not enhanced following
incubation with calcium (1.2 mM). TM expression appears to
be a consistent feature of squamous differentiation, as TM
staining is positively observed in stratified squamous epithelia
of various tissues, including skin, and oral mucosa, and in
squamous metaplasia of nonstratified epithelia (Raife et al.,
1994). It was demonstrated that E-cadherin is required for
calcium-induced keratinocyte differentiation (Tu et al., 2008).
In this study, we demonstrated that TM-null skin exhibited
striking downregulation of loricrin and filaggrin in stratified
keratinizing epithelia. Downregulation of these two major
protein markers in differentiating keratinocytes in the granular
cells and stratum corneum of stratified keratinizing epithelia
indicates that the differentiation process is compromised in
the TM-null keratinocytes. Similarly, our data showed that
calcium (1.2 mM) failed to promote the expression of epider-
mal differentiation markers in TM-null mouse keratinocytes
and TM-silenced human HaCaT cells, suggesting that
membrane-bound TM may participate in keratinocyte differ-
entiation process directly. In addition, loss of TM expression in
primary keratinocytes altered the location of E-cadherin at
cell–cell junction, suggesting that both TM and E-cadherin
may function synergistically in the process of keratinocyte
differentiation.
Consistent with previous studies showing that activation of
the Raf/MEK/ERK pathway has a crucial role in extracellular
calcium-induced keratinocyte differentiation (Schmidt et al.,
2000), we found that stable silencing of TM expression inhibits
ERK phosphorylation and cell differentiation. Intracellular
molecules, such as Rho or E-cadherin, are also required for
calcium-induced keratinocyte differentiation (Tu et al., 2008,
2011). These molecular pathways may probably be involved
in TM-regulated epithelial differentiation.
Our previous studies suggested that TM may function as a
calcium-dependent cell adhesion molecule (Huang et al.,
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(e, f) thrombomodulin (TM), and differentiation markers such as (g, h) filaggrin
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(a) Immunoblotting of TM expression in stable transfected HaCaT cells
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2003). In this study, the spreading areas of TM knockout
keratinocytes were significantly smaller than those of the
controls. Although keratinocyte-specific overexpression of
human TM did not affect normal squamous differentiation or
re-epithelialization of cutaneous wounds in previous studies
(Raife et al., 1998), our results showed that TM-null keratino-
cytes had reduced cell migration ability in cell culture within
24 hours, suggesting that membrane-bound TM may have a
role in cell migration. In addition, reduction of neovascu-
larization and epithelial proliferation near the wound area was
also observed in TM knockout skin. These findings confirm
our previous results showing that TM domains or sTM may
serve as an angiogenic and mitogenic factor for endothelial
and epithelial cells (Shi et al., 2005; Cheng et al., 2011).
The sTM fragments in plasma and urine are proposed to be
released from the cell surface by proteases and may serve as
diagnostic biomarkers of blood circulation disorders such as
coronary heart disease, or diabetes (Ishii and Majerus, 1985;
Gabat et al., 1996; Blann and Yip, 1998; Nakano et al., 1998;
Salomaa et al., 1998, 1999; Thorand et al., 2007). In this
study, reduction of sTM and decreased TM levels were
observed in primary cultured skin from TMlox/lox; K5-Cre
mice, and these mice exhibited delayed cutaneous wound
healing. Furthermore, treatment with recombinant TM
fragments (either mice rTMD23 or human rTMD123)
enhanced skin wound healing in TMlox/lox; K5-Cre mice. A
high degree of homology between human and mouse TM was
detected by protein alignment. Therefore, either human or
mouse TM fragments should be effective in promoting wound
healing in a mouse model. Our results suggest that TM in the
neoepidermis may have at least dual roles in wound healing.
The membrane-bound TM of keratinocytes is proposed to be
involved in the regulation of cell differentiation and migration.
On the other hand, the keratinocytes of the HE may serve as
the major source of sTM, which act as a paracrine factor to
modulate angiogenesis at the wound site and promote wound
healing.
Angiogenesis is an essential step of the wound healing
process, as new blood vessels are required for the supply of
oxygen and nutrients, debris removal, and granulation tissue
formation (Singer and Clark, 1999). Impaired skin blood flow
is a major pathologic event in diabetic wounds (Singer and
Clark, 1999; Khan et al., 2000). Our study, using tissue-
specific knockout mice, suggests that keratinocyte-specific TM
may be a critical regulator of keratinocyte differentiation and
cutaneous wound healing. Moreover, local treatment with
rTM fragments improved skin wound healing probably by
promoting neovascularization and epithelial proliferation.
Therefore, rTM might hold therapeutic potential in the
treatment of chronic wounds such as diabetic ulcers. In
conclusion, our study indicated that membrane-bound TM
has a critical role in epithelial differentiation and sTM holds
promise in promoting wound healing.
MATERIALS AND METHODS
Reagents
Anti-E-cadherin, antifilaggrin, and antiloricrin antibodies were pur-
chased from R&D Systems (Minneapolis, MN). Anti-TM, p-ERK, ERK,
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Figure 4. Reduction of spreading area and scratch-wound migration in primary cultured keratinocytes derived from TMlox/lox; K5-Cre mice. (a) Immunostaining
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glyceraldehyde-3-phosphate dehydrogenase, and b-actin antibodies
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The
rabbit polyclonal antibody against mouse rTMD23 was generated by
a local biotech company and purified with an affinity column of
rTMD23-conjugated Sepharose gel (Sigma Chemical, St Louis, MO).
The keratinocyte serum-free medium was purchased from Invitrogen
Life Technologies (Invitrogen, Carlsbad, CA).
Mouse strains
The conditional TM knockout mouse model (TMlox/lox) was generated
with Cre-recombinase systems described previously (Isermann et al.,
2001) and kindly provided by Dr Hartmut Weiler (Blood Research
Institute, The Blood Center of Wisconsin and the Medical College of
Wisconsin, Milwaukee, WI). The K5-Cre transgenic mice were kindly
provided by Dr Chun-Ming Chen at the National Yang-Ming
University (Taipei, Taiwan, Republic of China) (Liang et al., 2009).
The keratinocyte-specific TM deletion mice were generated by
crossing TMlox/lox mice with the K5-Cre transgenic mice. The TM
expression levels of offspring were analyzed by reverse transcriptase–
PCR and western blot analysis. All mouse lines were maintained by
backcrossing to C57BL/6J. All animal experiments were approved by
the Institutional Animal Care and Use Committee of National Cheng
Kung University, Tainan, Taiwan.
Murine keratinocyte primary culture
Primary keratinocytes were isolated from the mice tail skin and
cultured by using a modified protocol (Caldelari et al., 2000; Lichti
et al., 2008). In brief, the sterilized tail skins from mice were
incubated with dispase overnight at 4 1C, and the epidermis was
peeled carefully. After trypsinization of the epidermis, primary
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keratinocytes were collected and cultured with keratinocyte serum-
free medium in type IV collagen–coated dishes.
Cell spreading assay
Primary keratinocytes were seeded in type IV collagen (20mg ml 1;
BD Biosciences, Sparks, MD)–coated six-well plates. After 1-hour
incubation at 37 1C, nonattached cells were washed out by phos-
phate-buffered saline and attached cells were fixed with 4% for-
maldehyde. After staining with TM, multiple fields from each
treatment condition were photographed, and cell spreading areas
were measured by Metamorph software (Universal Imaging, Down-
ingtown, PA).
In vitro wound healing assay
As described previously, the cells were photographed using a time-
lapse video microscopy system (Olympus, Tokyo, Japan) immediately
after wounds were made (Cheng et al., 2011). The rate of wound
recovery was quantitatively determined with ImageJ software
(National Institutes of Health, Bethesda, MD). The percentage of
wound recovery at the indicated time points was calculated by
comparing it with the original wound area.
Stable transfected HaCaT cells
Silencing TM gene expression in HaCaT cells was accomplished
using short hairpin RNA technology with the pSM2c vector system
(GenDiscovery Biotechnology, New Taipei, Taiwan) (Kao et al.,
2010). HaCaT cells were transfected with the short hairpin RNA
expression construct or with empty vector and selected with
1mg ml 1 puromycin.
Reverse transcriptase–PCR
Total RNA was isolated from cultured keratinocytes using the TRIzol
reagent (Invitrogen). Total RNA (1mg) and oligo(dT) primer (Promega,
Madison, WI) were used for the complementary DNA synthesis. PCR
primers for TM and actin were: TM forward, 50-CTTGTGCAATAGG
AGCACGA-30 and TM reverse, 50-GACACAAAAATGCTCGCAGA-30;
and actin forward, 50-TGTTACCAACTGGGACGACA-30 and actin
reverse, 50-GGGGTGTTGAAGGTCTCAAA-30.
Western blot analysis
Approximately 50mg total protein was separated in a 10% SDS–
polyacrylamide gel and transferred onto a polyvinylidene difluoride
membrane. After probing with a primary and a secondary antibody,
the signal was detected using an enhanced chemiluminescence
reagent (Amersham Phamacia Biotech, Piscataway, NJ).
Histology
Tissue samples were fixed in 4% formaldehyde, embedded in
paraffin, and cut into 5-mm sections. For histological analysis, sections
were stained with hematoxylin and eosin or the indicated antibodies.
Secondary antibodies conjugated with Alexa Fluor 488 (Molecular
Probes, Eugene, OR) were used for immunofluorescence staining.
Expression and purification of rTMD proteins
The pPICZaA and pCR3 vectors (Invitrogen) were used for the
expression of mouse rTMD23 and human rTMD123 in the Pichia
pastoris and HEK293, separately (Shi et al., 2005). DNA fragments
encoding rTMD23 and rTMD123 were obtained as described
previously (Han et al., 2000). Conditioned medium containing
expressed mouse or human rTMD proteins were applied to a
nickel-chelating Sepharose column (Amersham Pharmacia Biotech
AB), and eluted under sterile conditions.
In vivo cutaneous wound healing assay
This assay was performed as described previously with modifications
(Tsuboi and Rifkin, 1990). The skin surrounding the wound was
treated with injections of the rTMD protein (125mg kg 1). This
treatment was applied to the wounds once per day at days 2 and 3
after injury. The cut edge of each wound was photographed at the
indicated time points after surgery for analysis of wound closure using
ImageJ software. The percentage of daily wound closure was
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Figure 6. Recombinant thrombomodulin (TM) fragments recover the delayed
skin wound healing in TMlox/lox; K5-Cre mice. (a) Western blot analysis of
soluble thrombomodulin (sTM) in concentrated conditional medium (med) and
TM protein in primary cultured skin lysate (lys) from TMlox/lox and TMlox/lox;
K5-Cre mice, separately. (b) Quantitative results of mice skin wound recovery
when treated with human rTMD123 (recombinant TM containing all the
ectodomains of TM) by subcutaneous injection. (c) Existence of rTMD123 at
indicated time points after the last injection. (d) Macroscopic observation of
wound recovery in the treatment of mice rTMD23 on TM knockout skin.
(e) Quantitative representation of the results of c. *Po0.05, **Po0.01 (n¼5).
Bar¼1 cm. K5-Cre, keratin 5-Cre recombinase.
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compared with the original wound area on day 1 after the wound
generation (Greenhalgh et al., 1990). The wound margins were
harvested to detect the retention of injected rTMD protein by
western blotting with the antibody to recognize human TM.
Statistical analysis
Data are expressed as mean±SD. Statistical significance was
analyzed using one-way analysis of variance and Student’s t-test.
The P-values of o0.05 were considered statistically significant.
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